Clinical Trial Update: Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation [Phase 4]

View source ↗

Summary

Phase 4 trial update for sacubitril/valsartan in heart failure with preserved ejection fraction and functional mitral regurgitation. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Ziekenhuis Oost-Limburg | Conditions: Heart Failure With Preserved Ejection Fraction, Functional Mitral Regurgitation | Phase 4 | Status: ACTIVE_NOT_RECRUITING